A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting

<div>Mean plasma concentration-time profiles of ramosetron after a single intravenous injection of 0.3, 0.45, and 0.6 mg of ramosetron. Bars represent standard errors.</div>

BioMed Research International

fig1

Figure 1

Figure 1: A Randomized, Double-Blind Pilot Study of Dose Comparison of Ramosetron to Prevent Chemotherapy-Induced Nausea and Vomiting 